196 related articles for article (PubMed ID: 15198358)
1. Invasive micropapillary carcinoma of the breast: clinicopathologic study of 62 cases of a poorly recognized variant with highly aggressive behavior.
Pettinato G; Manivel CJ; Panico L; Sparano L; Petrella G
Am J Clin Pathol; 2004 Jun; 121(6):857-66. PubMed ID: 15198358
[TBL] [Abstract][Full Text] [Related]
2. Infiltrating micropapillary carcinoma of the breast.
Middleton LP; Tressera F; Sobel ME; Bryant BR; Alburquerque A; Grases P; Merino MJ
Mod Pathol; 1999 May; 12(5):499-504. PubMed ID: 10349988
[TBL] [Abstract][Full Text] [Related]
3. Invasive micropapillary carcinoma of the breast: a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma.
Gokce H; Durak MG; Akin MM; Canda T; Balci P; Ellidokuz H; Demirkan B; Gorken IB; Sevinc AI; Kocdor MA; Saydam S; Harmancioglu O
Breast J; 2013; 19(4):374-81. PubMed ID: 23714006
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.
Kim MJ; Ro JY; Ahn SH; Kim HH; Kim SB; Gong G
Hum Pathol; 2006 Sep; 37(9):1217-26. PubMed ID: 16938528
[TBL] [Abstract][Full Text] [Related]
5. The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome in 'pure' ductal carcinoma in situ of the breast.
de Roos MA; van der Vegt B; Peterse JL; Patriarca C; de Vries J; de Bock GH; Wesseling J
Histopathology; 2007 Aug; 51(2):227-38. PubMed ID: 17650217
[TBL] [Abstract][Full Text] [Related]
6. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features.
Middleton LP; Amin M; Gwyn K; Theriault R; Sahin A
Cancer; 2003 Sep; 98(5):1055-60. PubMed ID: 12942575
[TBL] [Abstract][Full Text] [Related]
7. Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases.
Carter MR; Hornick JL; Lester S; Fletcher CD
Am J Surg Pathol; 2006 Mar; 30(3):300-9. PubMed ID: 16538049
[TBL] [Abstract][Full Text] [Related]
8. Breast carcinoma with micropapillary features: clinicopathologic study and long-term follow-up of 100 cases.
Chen L; Fan Y; Lang RG; Guo XJ; Sun YL; Cui LF; Liu FF; Wei J; Zhang XM; Fu L
Int J Surg Pathol; 2008 Apr; 16(2):155-63. PubMed ID: 18417672
[TBL] [Abstract][Full Text] [Related]
9. Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features.
Ramalingam P; Middleton LP; Tamboli P; Troncoso P; Silva EG; Ayala AG
Ann Diagn Pathol; 2003 Apr; 7(2):112-9. PubMed ID: 12715337
[TBL] [Abstract][Full Text] [Related]
10. Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity.
Walsh MM; Bleiweiss IJ
Hum Pathol; 2001 Jun; 32(6):583-9. PubMed ID: 11431712
[TBL] [Abstract][Full Text] [Related]
11. Cystic hypersecretory carcinoma: rare and poorly recognized variant of intraductal carcinoma of the breast. Report of five cases.
Skalova A; Ryska A; Kajo K; Di Palma S; Kinkor Z; Michal M
Histopathology; 2005 Jan; 46(1):43-9. PubMed ID: 15656885
[TBL] [Abstract][Full Text] [Related]
12. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
13. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
14. Importance of estrogen receptors for the behavior of invasive micropapillary carcinoma of the breast. Review of 68 cases with follow-up of 54.
Luna-Moré S; Casquero S; Pérez-Mellado A; Rius F; Weill B; Gornemann I
Pathol Res Pract; 2000; 196(1):35-9. PubMed ID: 10674270
[TBL] [Abstract][Full Text] [Related]
15. Role of E-cadherins in development of lymphatic tumor emboli.
Gupta A; Deshpande CG; Badve S
Cancer; 2003 May; 97(9):2341-7. PubMed ID: 12712492
[TBL] [Abstract][Full Text] [Related]
16. Invasive micropapillary carcinoma of breast: an under-recognized entity. a series of eight cases.
Uddin Z; Idrees R; Aftab K; Kayani N
Breast J; 2012; 18(3):267-71. PubMed ID: 22583197
[TBL] [Abstract][Full Text] [Related]
17. Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients.
Korkolis DP; Tsoli E; Fouskakis D; Yiotis J; Koullias GJ; Giannopoulos D; Papalambros E; Nikiteas NI; Spiliopoulou CA; Patsouris E; Asimacopoulos P; Gorgoulis VG
Anticancer Res; 2004; 24(3b):2061-8. PubMed ID: 15274401
[TBL] [Abstract][Full Text] [Related]
18. Invasive ductal carcinomas of the breast showing partial reversed cell polarity are associated with lymphatic tumor spread and may represent part of a spectrum of invasive micropapillary carcinoma.
Acs G; Esposito NN; Rakosy Z; Laronga C; Zhang PJ
Am J Surg Pathol; 2010 Nov; 34(11):1637-46. PubMed ID: 20975342
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen value as a marker in breast cancer.
Narita D; Cimpean AM; Anghel A; Raica M
Neoplasma; 2006; 53(2):161-7. PubMed ID: 16575473
[TBL] [Abstract][Full Text] [Related]
20. Invasive micropapillary carcinoma of the breast.
Siriaunkgul S; Tavassoli FA
Mod Pathol; 1993 Nov; 6(6):660-2. PubMed ID: 8302807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
